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Abstract
The amplification of the gene MYCN (V-myc mye-
locytomatosis viral-valeted oncogene, neuroblastoma
derived) has been a well-documented indicator for
poor prognosis in neuroblastoma, a childhood can-
cer. Unfortunately, there has been limited success in
understanding MYCN functionality in the landscape
of neuroblastoma and more importantly, given that
MYCN has been deemed “undruggable,” the need to
potentially illuminate key opportunities that indirectly
target MYCN is of great interest. To this end, this
work employs an emerging quantitative technique from
network science, namely network curvature, to quan-
tify the biological robustness of MYCN and its sur-
rounding neighborhood. In particular, when amplified
in Stage IV cancer, MYCN exhibits higher curvature
(more robust) than those samples with under expressed
MYCN levels. When examining the surrounding neigh-
borhood, the above argument still holds for network
curvature, but is lost when only analyzing differen-
tial expression - a common technique amongst oncol-
ogists and computational/molecular biologists. This
finding points to the problem (and possible solution) of
drug targeting in the context of complexity and indirect
cell signaling affects that have often been obfuscated
through traditional techniques.
1. Introduction
Neuroblastoma, the most common extra-cranial tu-
mor in childhood, is an embryonic tumor that is de-
rived from the neural crest [2]. It can occur anywhere
along the sympathetic nervous system, most com-
monly the adrenal glands in addition to the neck, chest,
abdomen, pelvis, and spine, and the clinical manifes-
tations are varied depending on location and severity.
The prognosis for low and intermediate risk neurob-
lastoma is excellent, whereas that for high risk disease
remains around 40% despite intensive chemotherapy
and myeloblative therapy with stem cell transplanta-
tion [1]. Other novel approaches have emerged in the
treatment of high risk disease; however drug resistance
continues to be the main obstacle in finding a cure for
this disease. One of the main indicators for high risk
neuroblastoma is MYCN amplification, found in ap-
proximately 25% of cases and correlated with poor
prognosis [3]. Although directly targeting MYCN is
not currently feasible, current efforts are underway to
inhibit targets directly or indirectly associated with the
gene. Motivated by such work, this note focuses to bet-
ter understand MYCN in a quantitative manner via bi-
ological robustness. In turn, targets of opportunity that
indirectly counter-effect MYCN (e.g., specific path-
ways) may be uncovered and furthered in the clinical
setting with respect to drug development.
To do so, we use the geometric network method
proposed in our previous work [4, 5]. These papers
are centered around several key concepts. Firstly,
cell signaling cascades within neuroblastoma can be
viewed as a complex biological network (weighted
graph) whereby the nodes in the network represent
genes and the edges characterize the “strength” of in-
teraction between such genes. Secondly, the underly-
ing network may be alternatively viewed as a discrete
statistical manifold for which those edge weights rep-
resent a one-step random walk. In doing so, we are
then able to show that Ricci curvature (from geom-
etry) is positively correlated with a networks robust-
ness [4]. Biologically speaking, this has allowed us to
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differentiate cancer tissue networks from their normal
counterparts on several tumor types, i.e., we were able
to quantitatively show that cancer is more robust than
normal tissue (given a precise definition of robustness
as given in Section 2.3). Using the same methodol-
ogy, we were further able to show that drug resistant
samples in Ewing Sarcoma were more robust than un-
treated and drug sensitive samples and that drug sen-
sitive samples exhibited fragility as compared to un-
treated samples [5]. Nevertheless, while in these previ-
ous works, we took a more global view in our analysis
of the cancer network, in the present work we consid-
ered a more localized analysis centered around MYCN
for neuroblastoma.
The remainder of the present note is outlined as fol-
lows: In the next section, we revisit the concept of
Ricci curvature in general and for the discrete case
of graphs. We further expound upon the flexibility of
providing a local proxy for robustness by introducing
discrete scalar curvature that is capable of account-
ing for inherent cell-signaling complexity. Section 3
then presents localized curvature results to illuminate
that MYCN amplification is robust and that it also pro-
motes robustness in the neighboring signaling region.
This is particularly compelling as differential expres-
sion is unable to elucidate such representative infor-
mation in this same neighborhood further stressing the
need for network science principles when performing
a quantitive analysis. We conclude this brief note with
Section 4 discussing future work.
2. Preliminaries
In this section, we provide background on geomet-
ric concept of curvature. We note that much of this
background can be similarly found in previous works
[4, 5, 6] and is simply provided here to make this note
more self-contained.
2.1. Introduction to Ricci Curvature
We begin with introducing some background on
Ricci curvature [7]; we refer the reader to [8] for all the
rigorous mathematical details. Accordingly, letX be a
Riemannian manifold (the generalization of a smooth
surface valid in any dimension). One can naturally
measure distances on X and thus define the length of
a given curve. Geodesics are curves that locally are
the shortest distance between two given points on the
manifold X , and are essential to defining curvature.
More specifically, let x ∈ X , let Tx denote the tan-
gent space at x with ux, w ∈ Tx denoting two orthog-
onal unit vectors. Then if we move along the geodesic
curve γ at x in the direction of w in an infinitesimal
manner, we let y ∈ X be the endpoint of the traver-
sal. A pictorial representation of this is given in Figure
1A-B. The transversal is carried out via parallel trans-
port, that roughly allows us to connect the geometry
of nearby points in a canonical manner [8]. We denote
by uy ∈ Ty, the result of the parallel transporting of
ux to the point y. On the plane, this would exactly
correspond to moving a given vector in a parallel man-
ner along a straight line (the geodesics of Euclidean
space). We call uy the parallel transport of ux .
On a curved space, geodesics defined along ux and
uy (denoted by expx tux and expy tuy, respectively)
may converge towards one another (positive curvature)
or diverge from one another (negative curvature); see
Figure 1C. The is called geodesic deviation. With this
in mind, we are able to define Ricci curvature via sec-
tional curvature [7, 8]. Again for uy the parallel trans-
port of u := ux from point x to y in the direction w,
we have for sufficiently small , δ > 0,
d(expx ux,expy uy)=δ(1−
2
2
K(u,w)+O(3+2δ)).
(1)
The termK(u,w) denotes the sectional curvature at x
in the tangent plane (u,w).
Classical Ricci curvature is defined by averaging
K(u,w) over all directions in the (u,w) tangent plane.
Of course, the above construction is defined in the con-
tinuous setting to provide an intuitive insight and we
will now turn our attention to the discrete setting that
will be needed for graphs and how we can measure the
fragility/complexity of MYCN within neuroblastoma.
2.2. Graph Ricci Curvature
Given we are working on a discrete graph/network
where ordinary notions of smoothness are not applica-
ble, we need to extend notions of Ricci curvature to
such a setting. We should note that there are number
of possibilities [11, 12, 13, 14, 15, 16, 17, 18] that are
geared towards extending the notion of Ricci curva-
ture to more general metric spaces. Here, we employ
a clever notion of a Ricci curvature, due to Ollivier
Figure 1. An Intuitive Understanding of Curvature. (A) Given a point x on a Riemannian manifold, one has a corresponding
tangent plane for which a set tangent vectors lie upon (i.e., ux). Locally, there exists a geodesic curve γ that for two close
enough points, the distance traveled along this curve represents the distance between such points. If one was to travel along
the tangent vector, the endpoint (which lies on the tangent space) may be mapped back to the manifold - this mapping is
known as the exponential map. (B) Using this basic geometric understanding, one may define the notion of curvature by
comparing two tangent vectors at two respective points connected by a geodesic in a given direction, which is shown to
be w in the above example. (C) From this, curvature is the deviation of such tangent vectors from a Euclidean space. In
the simplest Euclidean space, such endpoints of those vectors form a rectangle. In the case of the sphere, we have positive
curvature whereby geodesics along ux and uy converge. Similarly, in the case of negative curvature, they diverge.
[10, 9, 7], based on a synthetic coarse geometric ap-
proach. We will call this notion Ollivier-Ricci curva-
ture and Ricci curvature will always be taken to be in
this sense.
In order to define the Ollivier-Ricci curvature, we
will need to define the Wasserstein 1-distance (also
called the Earth Mover’s Distance) [19, 20] on a dis-
crete metric measure space X = {x1, ..., xn}. Let µ1
and µ2 denote two distributions having the same to-
tal mass, and denote by d(x, y) the distance between
x, y ∈ X (for graphs, taken as the hop metric). Then
W1(µ1, µ2) is be defined as follows [24]:
W1(µ1, µ2) = min
µ
n∑
i,j=1
d(xi, xj)µ(xi, xj) (2)
where µ(x, y) is a coupling (i.e., distribution on X ×
X) subject to the following constraints:
µ(x, y) ≥ 0 ∀x, y ∈ X (3)
n∑
i=1
µ(x, xi) = µ1(x) ∀x ∈ X (4)
n∑
i=1
µ(xi, y) = µ2(y) ∀y ∈ X. (5)
The cost above finds the optimal coupling of moving
mass defined by distribution µ1 to µ2 with minimal
“work.” Very importantly, the Wasserstein 1-distance
may be computed as a linear program allowing for an
efficient, highly parallelizable algorithm.
We can now define the Ollivier-Ricci curvature.
The intuition underpinning the approach is motivated
from the observation (in the classical continuous case)
that the distance between two small (geodesic) balls is
less than the distance between their centers on a posi-
tively curved space (and greater than the distance be-
tween the centers on a negatively curved one). Accord-
ingly, if we let (X, d) be metric space equipped with
a family of probability measures {µx : x ∈ X}, we
define the Ollivier-Ricci curvature κ(x, y) along the
geodesic connecting nodes x and y via
W1(µx, µy) = (1− κ(x, y))d(x, y), (6)
where W1 is the Wasserstein distance defined above
[19, 20, 21, 22, 23] and d is the distance on X . For the
case of weighted graphs, we set
dx =
∑
y
wxy (7)
µx(y) :=
wxy
dx
, (8)
where dx is the sum taken over all neighbors of node
x and where wxy denotes the weight of an edge con-
necting node x and node y (wxy = 0 if d(x, y) ≥ 2).
Figure 2. The constructed biological network of MYCN
neighborhood in neurbolastoma. (A) Direct interactions of
MYCN: NMI, MAX, AURKA, SP1 (B) Direct interactions
of NMI. (C) Direct interactions of AURKA. (D) Direct in-
teractions of SP1.
The measure µx may be regarded as the distribution
of a one-step random walk starting from x, with the
weight wxy quantifying the strength of interaction be-
tween nodal components or the diffusivity across the
corresponding link (edge).
2.3. Curvature and robustness
We summarize here the central relationship of cur-
vature and robustness, namely their positive correla-
tion. We express this as
∆R×∆Ric ≥ 0,
where ∆R denotes change in robustness and ∆Ric
change in curvature. This is strongly related to the
Fluctuation Theorem, which shows that changes in
entropy is positively correlated to changes robustness
[25], and this relationship has been exploited in [27]
for cancer as well. The relation between entropy and
curvature is described in [11] using deep results in the
theory of optimal transport.
We just note here that robustness is characterized by
the ability of a system to functionally adapt to changes
in the environment. The formal definition is based on
the theory of large deviations [26]. One considers ran-
dom fluctuations of a given network that result in per-
turbations of some observable. We let p(t) denote
the probability that the mean deviates by more than 
from the original (unperturbed) value at time t. Since
p(t) → 0 as t → ∞, we want to measure its relative
rate, that is, we set
R := lim
t→∞(−
1
t
log p(t)).
Therefore, large R means not much deviation and
small R large deviations.
Because of the positive correlation of curvature and
robustness, one can use curvature as a proxy for ro-
bustness. This gives a major advantage since curva-
ture may be computed via a linear program while the
computation for robustness may be quite challenging.
2.4. Weighted Graph Scalar Curvature
Based on our preceding discussion, the above mea-
sure of Ollivier-Ricci curvature provides a proxy for
edge (gene-to-gene interaction) robustness. This is
a local property capable of analyzing a pathway that
connects any two given genes or proteins in a biolog-
ical network. While this allows us to examine inter-
actions involving MYCN, we also seek to understand
MYCN as a stand alone gene, in the context of robust-
ness, compared to other genes involved in our network.
The important caveat here is a single gene (MYCN),
when measured in a given neighborhood (or globally),
must account for all direct and indirect interactions.
This is a problem of complexity–how can we quantita-
tively account for such enumerated pathways.
We approach the above issue via the related no-
tion of scalar curvature, which for intuitive purposes,
can be considered as the average of aforementioned
Ricci curvature. Specifically, scalar curvature at a
given node x can be defined on a discrete graph as
a weighted contraction with respect to the probabil-
ity distribution µx(y) as S(x) :=
∑
y µx(y)κ(x, y).
However, as mentioned, we would like to provide a
metric that is capable of measuring network robust-
ness in a localized region with respect to a particular
gene and in turn, must measure all pathways that inter-
act with that gene. As follows, we alternatively define
Table 1. This table presents scalar curvature results for Stage IV amplified and non-amplified MYCN cases. One can see
that curvature illustrates MYCN robustness. Note I: The average differential expression of MYCN in Amplified vs Non
Amplified: 0.7070 (Rank 261 out of ≈ 3.1 K genes). Note II: “Neighborhood” is defined as any gene that can be reached to
MYCN in two “hops.”
local-to-global “scalar” curvature Slg(x) as follows:
Slg(x) :=
1
Nyˆ
∑
yˆ
κ(x, y) (9)
where yˆ are those nodes that fall within a particular ξ-
geodesic neighborhood (i.e., yˆ = {y ∈ X : d(x, y) ≤
ξ}) and Ny are the number nodes yˆ. One could also
weight the above contraction with respect to the mea-
sure.
3. Results
Prior work [4] has shown that cancer networks
exhibits a higher degree of robustness as compared
to normal tissue networks. While we highlighted
the importance of understanding biological pathway
fragility, much of the analysis was conducted at a
macroscopic level over several cancer types. Here,
we provide a localized analysis of a single cancer
study (neuroblastoma) with an even more specific fo-
cus on a known poor prognosis indictor (amplification
of MYCN). To the best of our knowledge, this is the
first result to show that MYCN exhibits a higher degree
of biological robustness in Stage IV samples when am-
plified as opposed to non-amplified Stage IV samples.
However, before doing so, we first present details on
the obtained data and corresponding network construc-
tion.
3.1. Data and Network Construction
In this study, we obtained raw gene expres-
sion data from ArrayExpress (url: http://www.ebi.
ac.uk/arrayexpress, study: E-MTAB-1781). In par-
ticular, 709 neuroblastoma samples were available in-
cluding Stage I, Stage II, Stage IV tumor grades. There
was a total of 161 Stage IV samples for which MYCN
was considered “non-amplified” and 95 samples that
were considered “amplified.” In addition to this, 355
Stage I/II samples were available and used.
With regards to constructing the underlying inter-
actome (topology of the graph/network), we utilized
three separate databases: Human Protein Reference
Database (HPRD), Human Interactome Project (LIT)
and String v10. In particular, to ensure a highly accu-
rate neighborhood construction of the MYCN neigh-
borhood (e.g., those direct and primary indirect in-
teractions), we first sought out all possible interac-
tions that were listed in the HPRD and LIT database.
Then, such interactions were re-examined and recon-
structed by String v10 / Gene-Cards, taking only those
interactions with a high confidence (> .7) to “clean”
the neighborhood. The final result was further veri-
fied by our collarborators in the Division of Pediatric
Hematology/Oncology/Stem Cell Transplantation at
Columbia University, and the result of this neighbor-
hood can be seen in Figure 2. For the remaining inter-
actions, we used HPRD as our primary source for the
underlying network. Using the above raw expression
data, we were able to compute correlation between
any two given genes and these values served as the
weights in our corresponding network. Note: Given
that correlation ranges from [-1,1], we utilized an
affine transformation to ensure positive weights (i.e.,
cˆxy =
1
2(cxy + 1)). Accordingly, we built four sepa-
rate biological networks composed of ≈ 3.5K genes:
MYCN Amplified Stage IV, MYCN Non-Amplified
Stage IV, Stage IV (irrespective of MYCN amplifica-
tion), and Stage I/II (irrespective of MYCN amplifica-
tion).
3.2. Robustness of MYCN
We begin by computing Ricci curvature κ(x, y) on
Stage IV samples of both amplified and non-amplified
MYCN cases. In particular, while it is known that
MYCN amplification in “high risk” (Stage IV) patients
signify a poor outcome in terms of patient survivabil-
ity, there has been limited success in being able to
properly target MYCN and to further expound upon
the functionality of MYCN with respect to neuroblas-
toma. This said, using equation (9), we are able to
compute the changes in curvature (signifying changes
in robustness) on such samples. These results are seen
in Table 1. Interestingly, the neighborhood of MYCN,
defined to be only those interactions that are direct and
primary indirect interactions, exhibits higher scalar
curvature (more robust) than the non-amplified sam-
ples. In contrast, if one were to compute the the av-
erage differential expression of this neighborhood, in-
formation regarding MYCN significance is seemingly
“lost.” The significance of this result can be seen in
terms of gene ranking with respect to scalar curvature
and differential expression. Examining MYCN more
globally, i.e., taking all interactions involving MYCN,
we see that curvature is able to aptly characterize its
significance (via rank) as compared to simply differen-
tial expression. This quantification is consistent with
previous thinking and current on-going clinical work.
In addition, we also examined sample that comprise
Stage IV and Stage I/II data, regardless of MYCN am-
plification. These results can be seen in Table 2. While
MYCN is still considered to be “robust” in Stage IV
as compared to Stage I/II, the results are much less
pronounced. Biologically speaking, this would make
sense as cure rates for Stage I/II are considerably high
and do not need generally involve targeting MYCN,
i.e., MYCN is not considered to be a key factor con-
tributing to the robustness of neuroblastoma. Even fur-
ther and in Stage IV, MYCN has only been the focus
in those samples for which it has been amplified. In-
deed, the considerable risk that has been noted in clin-
ical outcomes primarily relies only on MYCN ampli-
fication in Stage IV cancer. Together, these two, al-
beit short studies, provide an interesting path forward
to understand how MYCN functions in the context of
drug resistance.
4. Future Work
To the best of our knowledge, this work provides
the first quantitive localized analysis with respect to
quantitive (biological) robustness of MYCN in neu-
roblastoma. In particular, through a network science
approach, we were able to show that those samples in
Stage IV neuroblastoma for which MYCN is ampli-
fied, also exhibits higher network curvature. Through
existing work [4], which suggests that increases in net-
work curvature is positively correlated to increases in
network robustness, we were able to deduce that such
findings point to the robustness of MYCN for “high
risk” patients. This is particularly compelling in that,
while differential expression is unable to elucidate the
importance of these indirect cell signaling affects, our
network curvature-based approach is able to do so.
From this, the next step, which will be a subject of fu-
ture research, is to quantify which feedback pathways
contribute to MYCN robustness and more importantly,
which drug targets may be considered (e.g., AURKA)
that will decrease such robustness.
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